Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients

Zahirah Zaharuddin, Nur Sabiha Md Hussin, Mahmathi Karuppannan

Open source

DOI
10.1038/s41598-024-75192-9
Published
2024-10-21
Container
Scientific Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-024-75192-9,
  title = {Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients},
  author = {Zahirah Zaharuddin and Nur Sabiha Md Hussin and Mahmathi Karuppannan},
  year = {2024},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-024-75192-9},
  url = {https://doi.org/10.1038/s41598-024-75192-9}
}

RIS

TY  - JOUR
TI  - Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients
AU  - Zahirah Zaharuddin
AU  - Nur Sabiha Md Hussin
AU  - Mahmathi Karuppannan
PY  - 2024
JO  - Scientific Reports
DO  - 10.1038/s41598-024-75192-9
UR  - https://doi.org/10.1038/s41598-024-75192-9
ER  - 

APA

Zaharuddin, Z., Hussin, N. S. M., & Karuppannan, M. (2024). Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients. Scientific Reports. https://doi.org/10.1038/s41598-024-75192-9

Source records